Cash on Hand for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported cash and short-term investments is $8.94B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$8.94B
YoY change
+12.2%
5Y CAGR
+4.6%
Peak year (2016)
$18.77B
Latest annual
$8.94B
Cash on Hand history chart for Abbott Laboratories (ABT) from 1985 to 2025
Cash on Hand history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $8.94B | +12.2% | ||
| 2024 | $7.97B | +9.5% | ||
| 2023 | $7.28B | -28.4% | ||
| 2022 | $10.17B | -0.8% | ||
| 2021 | $10.25B | +43.4% | ||
| 2020 | $7.15B | +72.7% | ||
| 2019 | $4.14B | +1.3% | ||
| 2018 | $4.09B | -57.5% | ||
| 2017 | $9.61B | -48.8% | ||
| 2016 | $18.77B | +206.5% | ||
| 2015 | $6.13B | +37.3% | ||
| 2014 | $4.46B | -44.9% | ||
| 2013 | $8.10B | -46.6% | ||
| 2012 | $15.17B | +87.4% | ||
| 2011 | $8.10B | +10.6% | ||
| 2010 | $7.32B | -26.3% | ||
| 2009 | $9.93B | +95.5% | ||
| 2008 | $5.08B | +80.1% | ||
| 2007 | $2.82B | +105.4% | ||
| 2006 | $1.37B | -53.5% | ||
| 2005 | $2.96B | +43.6% | ||
| 2004 | $2.06B | +60.1% | ||
| 2003 | $1.29B | +33.2% | ||
| 2002 | $966.13M | +35.4% | ||
| 2001 | $713.54M | -38.3% | ||
| 2000 | $1.16B | +59.9% | ||
| 1999 | $723.30M | +88.7% | ||
| 1998 | $383.32M | +48.0% | ||
| 1997 | $259.01M | +110.4% | ||
| 1996 | $123.08M | -61.0% | ||
| 1995 | $315.70M | +0.1% | ||
| 1994 | $315.33M | -16.8% | ||
| 1993 | $378.82M | +224.9% | ||
| 1992 | $116.60M | +93.0% | ||
| 1991 | $60.40M | +77.6% | ||
| 1990 | $34.00M | +150.0% | ||
| 1989 | $13.60M | -97.7% | ||
| 1988 | $582.60M | +12.1% | ||
| 1987 | $519.90M | +8.0% | ||
| 1986 | $481.60M | +10.1% | ||
| 1985 | $437.50M | — |
Cash on Hand values are taken from Abbott Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Abbott Laboratories (ABT) cash and short-term investments is $8.94B – grew 12.2% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories cash and short-term investments delivered a +4.6% annualised rate; sustaining 2 straight years of year-over-year growth.
Between 2016 and 2025, Abbott Laboratories cash and short-term investments plunged 52.4%, falling from $18.77B to $8.94B.
$18.77B stands as the all-time-high annual cash and short-term investments, posted in 2016, against a low of $13.60M during 1989.
Within Healthcare, Abbott Laboratories (ABT) ranks 6th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
Abbott Laboratories Cash on Hand by Year
Abbott Laboratories Cash on Hand 2025: $8.94B
Abbott Laboratories cash and short-term investments in 2025 was $8.94B, grew 12.2% from 2024.
Abbott Laboratories Cash on Hand 2024: $7.97B
Abbott Laboratories cash and short-term investments in 2024 was $7.97B, grew 9.5% from 2023.
Abbott Laboratories Cash on Hand 2023: $7.28B
Abbott Laboratories cash and short-term investments in 2023 was $7.28B, declined 28.4% below 2022.
Abbott Laboratories Cash on Hand 2022: $10.17B
Abbott Laboratories cash and short-term investments in 2022 was $10.17B, edged down 0.8% below 2021.
Abbott Laboratories Cash on Hand 2021: $10.25B
Abbott Laboratories cash and short-term investments in 2021 was $10.25B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Cash on Hand
Companies in the same sector as Abbott Laboratories, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's cash and short-term investments?
- Latest reported cash and short-term investments for Abbott Laboratories (ABT) is $8.94B (period ending December 31, 2025).
How has Abbott Laboratories cash and short-term investments changed year-over-year?
- Abbott Laboratories (ABT) cash and short-term investments changed +12.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories cash and short-term investments?
- Abbott Laboratories (ABT) cash and short-term investments compound annual growth rate is +4.6% over the most recent 5 years available.
When did Abbott Laboratories cash and short-term investments hit its highest annual value?
- Abbott Laboratories cash and short-term investments reached its highest annual value of $18.77B in 2016.
What was Abbott Laboratories cash and short-term investments in 2024?
- Abbott Laboratories (ABT) cash and short-term investments in 2024 was $7.97B.
What was Abbott Laboratories cash and short-term investments in 2025?
- Abbott Laboratories (ABT) cash and short-term investments in 2025 was $8.94B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.